Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Hemostasis01:05

Introduction to Hemostasis

9.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
9.4K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

9.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

968
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
968
Coagulation01:09

Coagulation

7.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.6K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

7.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.4K
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.3K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Macroscale and microscale mechanical and biochemical properties of the equine superficial digital flexor tendon are regionally dependent.

American journal of veterinary research·2026
Same author

Influence of liquid repellency and slipperiness on blood-material interactions.

Journal of materials chemistry. B·2026
Same author

Bacterial enzyme-responsive hydrogels for triggered delivery of antibiotics to infected wounds.

Science advances·2026
Same author

Dual Biomolecule Patterning on Micropatterned Polylactide Surfaces Bearing Oppositely Charged Polymer Brushes at Neighboring Sites.

ACS biomaterials science & engineering·2026
Same author

Smart Polymeric Biomaterials for Clinical Use.

Annual review of biomedical engineering·2026
Same author

Shea-derived cationic surfactants are effective and low-toxicity alternative co-surfactants for foam fractionation of per- and polyfluoroalkyl substances (PFAS).

Journal of hazardous materials·2026

Related Experiment Video

Updated: Oct 1, 2025

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

9.5K

Biomaterials for Hemostasis.

Aryssa Simpson1,2, Anita Shukla3, Ashley C Brown1,2

  • 1Joint Department of Biomedical Engineering, University of North Carolina-Chapel Hill and North Carolina State University, Raleigh, North Carolina, USA;

Annual Review of Biomedical Engineering
|March 1, 2022
PubMed
Summary

Controlling severe bleeding in emergencies requires advanced hemostatic materials. This review covers topical and injectable options for trauma and emergency medicine, focusing on ease of use in austere settings.

Keywords:
clottinghemostasislayer-by-layer assemblysealantsynthetic blood producttrauma

More Related Videos

TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application
08:40

TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application

Published on: June 8, 2016

14.3K
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

9.4K

Related Experiment Videos

Last Updated: Oct 1, 2025

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

9.5K
TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application
08:40

TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application

Published on: June 8, 2016

14.3K
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

9.4K

Area of Science:

  • Emergency Medicine
  • Biomaterials Science
  • Trauma Surgery

Background:

  • Uncontrolled bleeding poses a significant threat in trauma and emergency situations.
  • Current hemostatic materials often require specific storage and deployment conditions.
  • Emergency medicine demands materials suitable for austere environments, easy transport, and room-temperature storage.

Purpose of the Study:

  • To review existing and emerging hemostatic materials for emergency medicine.
  • To highlight the design considerations for materials used in austere environments.
  • To provide an overview of both topical and injectable hemostatic solutions.

Main Methods:

  • Literature review of natural and synthetic hemostatic materials.
  • Analysis of material properties relevant to emergency deployment.
  • Categorization of hemostats into topical and injectable classes.

Main Results:

  • Various natural and synthetic materials have been investigated for hemostatic applications.
  • Injectable hemostats represent a newer development with potential for emergency use.
  • Material design must consider factors like shelf-life, transportability, and ease of application.

Conclusions:

  • Hemostatic materials are crucial for managing uncontrolled bleeding in emergency settings.
  • Further development is needed for materials optimized for austere environments.
  • Both topical and injectable hemostats offer promising avenues for improving trauma care.